Show simple item record

dc.contributor.authorZagadailov, E
dc.contributor.authorCorman, S
dc.contributor.authorHagan, M
dc.contributor.authorChirikov, V
dc.contributor.authorJohnson, C
dc.contributor.authorMacahilig, C
dc.contributor.authorSeal, B
dc.contributor.authorDalal, M
dc.contributor.authorIllidge, Timothy M
dc.contributor.authorBrockelmann, P J
dc.date.accessioned2017-03-20T11:17:20Z
dc.date.available2017-03-20T11:17:20Z
dc.date.issued2016
dc.identifier.citationRisk factors for relapse in patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant: a real-world analysis in Germany and the United Kingdom. 2016, 101(s5): 51-52 Haematologicaen
dc.identifier.urihttp://hdl.handle.net/10541/620209
dc.language.isoenen
dc.titleRisk factors for relapse in patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant: a real-world analysis in Germany and the United Kingdom.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMillennium Pharmaceuticals, Inc., Cambridge, MA, USAen
dc.identifier.journalHaematologicaen
dc.description.collectionLymphoma Research Teamen


This item appears in the following Collection(s)

Show simple item record